Your browser doesn't support javascript.
loading
Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
Schramm, Amelie; Schochter, Fabienne; Friedl, Thomas W P; de Gregorio, Nikolaus; Andergassen, Ulrich; Alunni-Fabbroni, Marianna; Trapp, Elisabeth; Jaeger, Bernadette; Heinrich, Georg; Camara, Oumar; Decker, Thomas; Ober, Angelika; Mahner, Sven; Fehm, Tanja N; Pantel, Klaus; Fasching, Peter A; Schneeweiss, Andreas; Janni, Wolfgang; Rack, Brigitte K.
Afiliación
  • Schramm A; Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany. Electronic address: Amelie.Schramm@uniklinik-ulm.de.
  • Schochter F; Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany.
  • Friedl TWP; Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany.
  • de Gregorio N; Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany.
  • Andergassen U; Department of Obstetrics and Gynecology, Ludwig Maximilians University, Munich, Germany.
  • Alunni-Fabbroni M; Department of Obstetrics and Gynecology, Ludwig Maximilians University, Munich, Germany.
  • Trapp E; Department of Obstetrics and Gynecology, Ludwig Maximilians University, Munich, Germany.
  • Jaeger B; Department of Obstetrics and Gynecology, Heinrich Heine University, Duesseldorf, Germany.
  • Heinrich G; Medical Office of Gynecology, Fürstenwalde, Germany.
  • Camara O; Department of Obstetrics and Gynecology, Hufeland Hospital, Bad Langensalza, Germany.
  • Decker T; Medical Office of Oncology, Ravensburg, Germany.
  • Ober A; Department of Gynecology, St Vincenz Hospital Limburg, Limburg, Germany.
  • Mahner S; Department of Obstetrics and Gynecology, Ludwig Maximilians University, Munich, Germany.
  • Fehm TN; Department of Obstetrics and Gynecology, Heinrich Heine University, Duesseldorf, Germany.
  • Pantel K; Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Fasching PA; Department of Obstetrics and Gynecology, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Schneeweiss A; National Center for Tumor Diseases, Heidelberg, Germany.
  • Janni W; Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany.
  • Rack BK; Department of Obstetrics and Gynecology, Ludwig Maximilians University, Munich, Germany.
Clin Breast Cancer ; 17(4): 279-285, 2017 07.
Article en En | MEDLINE | ID: mdl-28190761
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Carcinoma Lobular / Carcinoma Ductal de Mama / Células Neoplásicas Circulantes Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Carcinoma Lobular / Carcinoma Ductal de Mama / Células Neoplásicas Circulantes Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos